The alliance aims at bringing high-level clinical and regulatory consulting services to China, as well as identify medical devices, drugs and biologics to be exported to China and subsequently distributed by Sinopharm Foreign Trade.
Becker & Associates is currently managing several large projects in China, including advising a major Chinese pharmaceutical manufacturing company as it seeks to be the first Chinese company to gain FDA approval to sell finished goods in the US.
Becker & Associates CEO Karen Becker said, “Our partner has a tremendous footprint in China as part of the Sinopharm Group, which manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China.”
US-based Becker & Associates Consulting is a provider of FDA consulting services for the medical device, pharmaceutical and biologics industry.